NDC 0591-0301 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-0301
- Package NDCs from labels
- 0591-0301-01, 0591-0301-10
- Manufacturer
- Watson Labs
- Effective date
- 2007-05-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Watson Labs | Watson Labs | 2007-05-28 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-0301-01 | Furosemide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 0591-0301-10 | Furosemide | 1000 in 1 BOTTLE | TABLET | 1000 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Furosemide | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | |
| Furosemide | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | |
| Corn starch | INACTIVE INGREDIENT | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | ||
| Lactose monohydrate | INACTIVE INGREDIENT | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | ||
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | |
| Microcrystalline cellulose | INACTIVE INGREDIENT | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 3f6529fb-1173-ada3-e063-6294a90a76cb | 2025-10-13 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 6194face-c26c-46ed-bde7-1e29bfeabd88 | 2025-10-02 | Warnings, Adverse reactions | 313988 |
| Lasix | FUROSEMIDE | Validus Pharmaceuticals LLC | 2c9b4d8f-0770-482d-a9e6-9c616a440b1a | 2025-09-30 | Warnings, Adverse reactions | 313988 197732 310429 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 53c3f50f-57c6-441b-afea-ec43d7943d1a | 2025-09-29 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | Coupler LLC | 3eed4bbf-7d0e-e852-e063-6394a90a85c2 | 2025-09-16 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 48d8f490-e9d1-4c95-ab2f-414d3f4a9df4 | 2025-08-18 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | c24489c3-65e0-44e3-a50a-8bb0672e8821 | 2025-08-15 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 52e75604-5766-40e8-a13a-8c449e06ebda | 2025-08-15 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 12137a90-fb35-45d7-8984-0b04793d3e34 | 2025-08-15 | Warnings, Adverse reactions | 197732 |
| FUROSEMIDE | FUROSEMIDE | Aurobindo Pharma Limited | a504ee4b-3995-45f2-898c-91116dd81d19 | 2025-07-19 | Warnings, Adverse reactions | 313988 197732 310429 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 3ba730ab-90d4-478a-80b3-1ea3edb03e4d | 2025-07-15 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | Proficient Rx LP | 600ca175-be2b-4c43-b119-133ae21a5601 | 2025-07-01 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | Solco Healthcare LLC | 6a0fb397-63ae-4fce-bddf-16a91b1b7a2f | 2025-06-18 | Warnings, Adverse reactions | 313988 197732 310429 |
| UDSxMP Medicated System | FUROSEMIDE, BENZALKONIUM CHLORIDE | Wellbeing Medical Supply | 06b901dc-0f1d-424f-8c4b-a29113cbab25 | 2025-06-12 | Warnings, Adverse reactions | 310429 |
| UDSx Medicated System | FUROSEMIDE, BENZALKONIUM CHLORIDE | Wellbeing Medical Supply | 8f1df75b-101a-45da-924a-2767c34a4efe | 2025-06-12 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | Prefferred Pharmaceuticals Inc. | ede9846b-b4c5-4be2-9188-fd65e66cd893 | 2025-04-30 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | Coupler LLC | 33ec71e2-8fbd-0703-e063-6294a90a62e1 | 2025-04-29 | Warnings, Adverse reactions | 197732 |
| Furosemide | FUROSEMIDE | Chartwell RX, LLC | 8ebd2f10-acfc-48a4-a5db-f20377bda9ce | 2025-03-26 | Warnings, Adverse reactions | 313988 310429 |
| Furosemide | FUROSEMIDE | Rising Pharma Holdings, Inc. | 6101b9b4-f3ef-438e-a857-b4ea55ffc679 | 2025-02-21 | Warnings, Adverse reactions | 313988 197732 310429 |
| Furosemide | FUROSEMIDE | Ipca Laboratories Limited | 0acd293b-ecab-4879-a8e7-cd1b76148f2a | 2025-01-20 | Warnings, Adverse reactions | 313988 197732 310429 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.